Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial

[1]  M. Schrappe,et al.  A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group. , 1996, Blood.

[2]  E. Thiel,et al.  Improved outcome in adult B-cell acute lymphoblastic leukemia. , 1996, Blood.

[3]  K. Chow,et al.  Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  G. Rosner,et al.  Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study. , 1995, Cytokine.

[5]  K. Spiekermann,et al.  Altered surface marker expression and function of G‐CSF‐induced neutrophils from test subjects and patients under chemotherapy , 1994, British journal of haematology.

[6]  A. Elias,et al.  Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Sonis,et al.  Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. , 1992, Oral surgery, oral medicine, and oral pathology.

[8]  J. Szer,et al.  Studies of oral neutrophil levels in patients receiving G‐CSF after autologous marrow transplantation , 1992, British journal of haematology.

[9]  T. Therneau,et al.  Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Kenny,et al.  Effect of two oral care protocols on the incidence of stomatitis in hematology patients , 1990, Cancer nursing.

[11]  L. Young,et al.  From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. , 1990, The Journal of infectious diseases.

[12]  C. Pratt.  Ifosfamide studies for primary or recurrent pediatric malignant solid tumors and leukemia. , 1990, Seminars in oncology.

[13]  J. Groopman.  Status of colony-stimulating factors in cancer and AIDS. , 1990, Seminars in oncology.

[14]  J. Gabrilove,et al.  Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium , 1989 .

[15]  O. Bergmann.  Oral infections and septicemia in immunocompromised patients with hematologic malignancies , 1988, Journal of clinical microbiology.

[16]  M. Slevin,et al.  Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. , 1985, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  S. Sonis,et al.  Oral complications in patients receiving treatment for malignancies other than of the head and neck. , 1978, Journal of the American Dental Association.

[18]  R. Prentice.  Linear rank tests with right censored data , 1978 .

[19]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[20]  Y. S. Sathe,et al.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.

[21]  W. Vogler,et al.  TOXICITY AND ANTITUMOR EFFECT OF DIVIDED DOSES OF METHOTREXATE. , 1965, Archives of internal medicine.